ATP ion channel P2X purinergic receptors in inflammation response.
ATP
Antagonists
Inflammatory responses
P2X receptors
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
17
11
2022
revised:
19
12
2022
accepted:
30
12
2022
entrez:
14
3
2023
pubmed:
15
3
2023
medline:
16
3
2023
Statut:
ppublish
Résumé
Different studies have confirmed that P2X purinergic receptors play a key role in inflammation. Activation of P2X purinergic receptors can release inflammatory cytokines and participate in the progression of inflammatory diseases. In an inflammatory microenvironment, cells can release a large amount of ATP to activate P2X receptors, open non-selective cation channels, activate multiple intracellular signaling, release multiple inflammatory cytokines, amplify inflammatory response. While P2X4 and P2X7 receptors play an important role in the process of inflammation. P2X4 receptor can mediate the activation of microglia involved in neuroinflammation, and P2X7 receptor can mediate different inflammatory cells to mediate the progression of tissue-wide inflammation. At present, the role of P2X receptors in inflammatory response has been widely recognized and affirmed. Therefore, in this paper, we discussed the role of P2X receptors-mediated inflammation. Moreover, we also described the effects of some antagonists (such as A-438079, 5-BDBD, A-804598, A-839977, and A-740003) on inflammation relief by antagonizing the activities of P2X receptors.
Identifiants
pubmed: 36916431
pii: S0753-3322(22)01594-3
doi: 10.1016/j.biopha.2022.114205
pii:
doi:
Substances chimiques
Cytokines
0
Ion Channels
0
Receptors, Purinergic P2X4
0
Receptors, Purinergic P2X7
0
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
114205Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.